Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia 33Leukemia, Lymphocytic, Chronic, B-Cell 26Lymphoma 19Myelodysplastic Syndromes 16Hodgkin Disease 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Multiple Myeloma 10Leukemia, Myeloid, Acute 10Lymphoma, Non-Hodgkin 8Lymphoma, Mantle-Cell 7Lymphoma, Follicular 7Recurrence 6Myeloproliferative Disorders 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Chronic-Phase 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Hematologic Neoplasms 5Waldenstrom Macroglobulinemia 4Neoplasms, Plasma Cell 4Lymphoma, T-Cell, Cutaneous 4Congenital Abnormalities 4Burkitt Lymphoma 4Anemia, Aplastic 4Sezary Syndrome 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic-Myeloproliferative Diseases 3Mycosis Fungoides 3Lymphoma, T-Cell, Peripheral 3Lymphoma, Large-Cell, Immunoblastic 3

Interventions

ibrutinib 4fludarabine phosphate 4fludarabine 4Rituximab 4Bendamustine Hydrochloride 3blinatumomab 2Melphalan 2Lenalidomide 2Cyclophosphamide 2Busulfan 2Alemtuzumab 2thymoglobulin 1sargramostim 1pirtobrutinib 1pegaspargase 1palbociclib 1ofatumumab 1obinutuzumab 1lirilumab 1copanlisib 1Vincristine 1RFT5-SMPT-dgA immunotoxin 1Prednisone 1Prednisolone 1Mycophenolic Acid 1Methotrexate 1Mesna 1Leukapheresis 1Immunotherapy, Adoptive 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Leukemia, Lymphoid × Alemtuzumab × Clear all
NCT00935792 2017-09-26

Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Mayo Clinic

Phase 1/2 Completed
28 enrolled 13 charts
Other hematologic neoplasm

Leukemia, Lymphoid, Hematologic Neoplasms

NCT00683046 2016-11-22

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

University of Chicago

Phase 2 Completed
204 enrolled 7 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Aplastic, Blast Crisis, Hodgkin Disease, Leukemia, Lymphoid, Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡